
iPSC Generation
- Best suited for: PBMCs & fibroblasts
- Available enhancements: Oct4, Sox2, Klf4, cMyc RNA
- Best suited for: Reprogramming, disease modeling

WORKFLOW KIT · CELL ENGINEERING
Deliver cytokine armoring, gene knockouts, and functional enhancers into primary human T cells.
Every kit includes: Portal-sourced RNA · Optimized protocols · MicroBooster™ cartridges · Suggested readouts · Reagents

Co-deliver mRNA, siRNA, CRISPR RNP, and proteins into the same primary T cell in a single step, without viral vectors or electroporation, so you can arm, edit, and trace cells in one workflow while keeping them healthy.
The problem
Functional enhancement of primary T cells usually means stacking separate steps, one for editing, one for cytokine support, one for a reporter, each with its own viral vector or electroporation hit. Resting T cells are especially hard to engineer, and every added round costs viability and time.
With this kit
Portal's Gateway™ mechanoporation transiently opens primary T cells with a gentle mechanical squeeze, letting you co-deliver mRNA, CRISPR RNP, and tracers together. mRNA expresses within hours and knockouts appear by 24h+, all in unstimulated cells, with a phenotype that stays closer to untouched controls than electroporation.
Every Portal kit runs the same five steps. The cargo and the readout change from kit to kit. The Gateway™ boost stays the same.
Portal has the Solution
01
Isolate
T cells, PBMCs, or target cell type
02
Mix
Cells + cargo (RNA / RNP / both)

03
Boost
Gateway™ mechanoporation
04
Rest & Expand
RNA expression within hrs; KO at 24h+
05
Assay
Cytotoxicity / expression
Unbiased, validated intracellular hits
85+%
Multiplex-delivered T cells (GFP⁺ / B2M-edited / tracer⁺)
Multiplexed
Multiple RNPs and RNAs in a single boost
Across Cell States
Unstimulated T cells, activated T cells, and TILs
The cargo and protocols below make this kit specific. The core consumables, settings, and support ship with every Portal kit.
Available Cargoes
Reagents & Consumables
Protocol & Settings
Support
Available Cargoes
Reagents & Consumables
Protocol & Settings
Support
T cells boosted with CRISPR RNP, mRNA, and Dextran together. In unstimulated T cells, ~85.7% were positive for GFP expression, B2M editing, and dextran delivery after a single boost.
T cells engineered with simultaneous circRNA delivery of a CD19 CAR and mbIL-12. Boosted cells co-express both, and cytotoxicity rises with the effector-to-target ratio.
Engineering TILs to express membrane-bound IL-2 and IL-12 improves expansion and enriches for central-memory-like cells while decreasing terminal-effector-like cells.
Fewer misregulated genes than electroporation at 6h and 24h post-delivery. Mechanoporated T cells stay closer to untouched controls. (DiTommaso et al., 2018, PNAS.)
Portal — enabling live-cell assays, target engagement, and compound profiling.
Kits include: Optimized protocols · Portal reagents · Delivery cartridges · Suggested readouts